E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/7/2016 in the Prospect News PIPE Daily.

NuGene completes $245,000 private placement of $275,000 convertibles

Deal sells original issue discount note due 2016 to Gemini Master Fund

By Devika Patel

Knoxville, Tenn., April 7 – NuGene International, Inc. completed a private placement of a $275,000 convertible note for $245,000, net of costs and original issue discount, on April 4, according to an 8-K filed Thursday with the Securities and Exchange Commission. The deal with Gemini Master Fund, Ltd. priced on March 30.

The 8% note matures Dec. 31, 2016 and is initially convertible into common stock at $0.70 per share, a 4.48% premium to the March 29 closing share price of $0.67.

The note may be prepaid at 112.

The Irvine, Calif., company develops cosmeceuticals.

Issuer:NuGene International, Inc.
Issue:Convertible note
Amount:$275,000
Maturity:Dec. 31, 2016
Price:$245,000
Coupon:8%
Conversion price:$0.70
Conversion premium:4.48%
Call option:At 112
Warrants:No
Investor:Gemini Master Fund, Ltd.
Pricing date:March 30
Settlement date:April 4
Stock symbol:OTCBB: NUGN
Stock price:$0.67 at close March 29
Market capitalization:$24.75 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.